[Profile] Katie Anders—improving global dengue control
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00012-5/fulltext?rss=yes
Katherine (Katie) Anders grew up in an academic home in Melbourne, VIC, Australia with a malariologist father and an immunologist mother. “Discussions about human biology and disease, health inequities, and advances in medical science were standard meal-time conversations at our house: it was subliminal exposure to a scientific way of thinking from an early age”, Anders told The Lancet Infectious Diseases. And while she initially resisted an academic career path, an interest in medicine and science was always there.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00012-5/fulltext?rss=yes
Katherine (Katie) Anders grew up in an academic home in Melbourne, VIC, Australia with a malariologist father and an immunologist mother. “Discussions about human biology and disease, health inequities, and advances in medical science were standard meal-time conversations at our house: it was subliminal exposure to a scientific way of thinking from an early age”, Anders told The Lancet Infectious Diseases. And while she initially resisted an academic career path, an interest in medicine and science was always there.
[Newsdesk] CDC cuts to childhood vaccine recommendations
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00014-9/fulltext?rss=yes
New childhood vaccine recommendations from the US Centers for Disease Control and Prevention have been widely criticised by experts. Priya Venkatesan reports.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00014-9/fulltext?rss=yes
New childhood vaccine recommendations from the US Centers for Disease Control and Prevention have been widely criticised by experts. Priya Venkatesan reports.
[Newsdesk] Brazil approves domestic single-shot dengue vaccine
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00013-7/fulltext?rss=yes
In December 2025, the domestically produced Butantan-DV vaccine was approved by Brazil's regulatory agency for use in individuals aged 12–59 years. Marcia Triunfol reports.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00013-7/fulltext?rss=yes
In December 2025, the domestically produced Butantan-DV vaccine was approved by Brazil's regulatory agency for use in individuals aged 12–59 years. Marcia Triunfol reports.
Retrospective Case Series of Ocular Lyme Disease, 1988–2025
https://wwwnc.cdc.gov/eid/article/32/1/25-0769_article
https://wwwnc.cdc.gov/eid/article/32/1/25-0769_article
Emerging Infectious Diseases journal
Retrospective Case Series of Ocular Lyme Disease, 1988–2025
Reports of ocular manifestations are uncommon, and signs and symptoms may be overlooked by physicians.
Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025
https://wwwnc.cdc.gov/eid/article/32/2/25-1332_article
https://wwwnc.cdc.gov/eid/article/32/2/25-1332_article
Emerging Infectious Diseases journal
Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025
❤1
[Comment] Lessons from Brazil's elimination of vertical HIV transmission
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00002-0/fulltext?rss=yes
In 2025, WHO's validation of Brazil for the elimination of vertical transmission of HIV (sometimes referred to as mother-to-child transmission of HIV) is a landmark global public health achievement.1 As the most populous country to reach this milestone, Brazil shows that elimination is feasible even in large, socially diverse, and unequal settings when political commitment, universal health coverage, and human rights are placed at the centre of health policy.1 This success highlights the urgency for countries in sub-Saharan Africa to implement concrete, scalable, and equity-oriented strategies to achieve similar progress in eliminating vertical transmission of HIV.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00002-0/fulltext?rss=yes
In 2025, WHO's validation of Brazil for the elimination of vertical transmission of HIV (sometimes referred to as mother-to-child transmission of HIV) is a landmark global public health achievement.1 As the most populous country to reach this milestone, Brazil shows that elimination is feasible even in large, socially diverse, and unequal settings when political commitment, universal health coverage, and human rights are placed at the centre of health policy.1 This success highlights the urgency for countries in sub-Saharan Africa to implement concrete, scalable, and equity-oriented strategies to achieve similar progress in eliminating vertical transmission of HIV.
[Articles] Acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00241-3/fulltext?rss=yes
Acceptability and tolerability of intramuscular cabotegravir–rilpivirine remained high through to 48 weeks of treatment, suggesting that this long-acting intramuscular treatment approach is well received by diverse populations of adolescents with HIV across multiple settings.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00241-3/fulltext?rss=yes
Acceptability and tolerability of intramuscular cabotegravir–rilpivirine remained high through to 48 weeks of treatment, suggesting that this long-acting intramuscular treatment approach is well received by diverse populations of adolescents with HIV across multiple settings.
❤2
[Articles] Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir–rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00242-5/fulltext?rss=yes
Week 48 data from the first virologically suppressed adolescents with HIV-1 who switched from daily oral to intramuscular cabotegravir and intramuscular rilpivirine every 8 weeks showed favourable safety, pharmacokinetics, and virological suppression informing both real-world use, where approved, and ongoing regulatory submissions, where approval is pending.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00242-5/fulltext?rss=yes
Week 48 data from the first virologically suppressed adolescents with HIV-1 who switched from daily oral to intramuscular cabotegravir and intramuscular rilpivirine every 8 weeks showed favourable safety, pharmacokinetics, and virological suppression informing both real-world use, where approved, and ongoing regulatory submissions, where approval is pending.
A Diabetic Man With Fever, Cough, and Necrotic Eschar
https://academic.oup.com/cid/article/81/6/1209/8460704?rss=1
https://academic.oup.com/cid/article/81/6/1209/8460704?rss=1
OUP Academic
A Diabetic Man With Fever, Cough, and Necrotic Eschar
A 72-year-old male presented with pyrexia, cough with sputum production, and a rash on his back. Three weeks prior, a fever of 39°C had developed, along wi
State-of-the-Art Review: Congenital Syphilis in the Modern Era: Current Strategies and Future Directions
https://academic.oup.com/cid/article/81/6/1023/8460680?rss=1
https://academic.oup.com/cid/article/81/6/1023/8460680?rss=1
OUP Academic
State-of-the-Art Review: Congenital Syphilis in the Modern Era: Current Strategies and Future Directions Free
Utilizing case-based vignettes as an orientation, this State-of-the-Art Review examines the most up-to-date epidemiology, pathophysiology, clinical managem
Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia
https://wwwnc.cdc.gov/eid/article/32/3/25-0832_article
https://wwwnc.cdc.gov/eid/article/32/3/25-0832_article
Emerging Infectious Diseases journal
Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia
A 46-Year-Old With Persistent Altered Mental Status and Respiratory Failure
https://academic.oup.com/cid/article/82/1/159/8468376?rss=1
https://academic.oup.com/cid/article/82/1/159/8468376?rss=1
OUP Academic
A 46-Year-Old With Persistent Altered Mental Status and Respiratory Failure
Question:
State-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis
https://academic.oup.com/cid/article/82/1/1/8468374?rss=1
https://academic.oup.com/cid/article/82/1/1/8468374?rss=1
OUP Academic
State-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis Free
Abstract. Acute bacterial prostatitis (ABP) and chronic bacterial prostatitis (CBP) are poorly defined clinical entities, and diagnosis can be challenging.
Genomic Analysis of Doxycycline Resistance–Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum
https://wwwnc.cdc.gov/eid/article/32/2/25-1060_article
https://wwwnc.cdc.gov/eid/article/32/2/25-1060_article
Emerging Infectious Diseases journal
Genomic Analysis of Doxycycline Resistance–Associated 16S rRNA Mutations in <em>Treponema pallidum</em> Subspecies <em>pallidum</em>
Mutations in <em>Treponema pallidum</em> subsp. <em>pallidum</em>
Characteristics and Transmission Dynamics of Global Travel-Related Mpox Cases Caused by Clade Ib Monkeypox Virus
https://wwwnc.cdc.gov/eid/article/32/2/25-1530_article
https://wwwnc.cdc.gov/eid/article/32/2/25-1530_article
Emerging Infectious Diseases journal
Characteristics and Transmission Dynamics of Global Travel-Related Mpox Cases Caused by Clade Ib Monkeypox Virus
Travel-Related Mpox Cases Caused by Clade Ib MPXV